Keyphrases
Pulmonary Tuberculosis
100%
Moxifloxacin
100%
Intensive Phase
100%
Placebo
25%
Cavitation
25%
Ethambutol
12%
Rifampin
12%
Clinical Trials
12%
Multivariate Analysis
12%
Mouse Model
12%
Mycobacterium Tuberculosis (M. tb)
12%
Combination Therapy
12%
Directly Observed
12%
Efficacy Analysis
12%
Antimicrobial Activity
12%
HIV-positive
12%
TB Chemotherapy
12%
Sputum Culture
12%
Antimicrobial Safety
12%
Anti-tuberculosis
12%
Sputum Smear Positive
12%
Pyrazinamide
12%
Sputum
12%
Chest Radiograph
12%
Negative Culture
12%
Medicine and Dentistry
Lung Tuberculosis
100%
Isoniazid
100%
Moxifloxacin
100%
Placebo
25%
Arm
25%
Ethambutol
12%
Human Immunodeficiency Virus
12%
Clinical Trial
12%
Combination Therapy
12%
Mycobacterium Tuberculosis
12%
In Vitro
12%
Multivariate Analysis
12%
Antimicrobial Activity
12%
Sputum Smear
12%
Rifampicin
12%
Pyrazinamide
12%
Sputum
12%
Sputum Culture
12%
Thorax Radiography
12%
Chemotherapy
12%
Antimicrobial Agent
12%
Immunology and Microbiology
Arm
100%
Sputum
100%
Human Immunodeficiency Virus
50%
Mouse Model
50%
Mycobacterium Tuberculosis
50%
Antimicrobial Activity
50%
Sputum Culture
50%
Antimicrobial Agent
50%
Pharmacology, Toxicology and Pharmaceutical Science
Lung Tuberculosis
100%
Isoniazid
100%
Moxifloxacin
100%
Placebo
25%
Ethambutol
12%
Mouse Model
12%
HIV
12%
Clinical Trial
12%
Chemotherapy
12%
Combination Therapy
12%
Mycobacterium Tuberculosis
12%
Rifampicin
12%
Pyrazinamide
12%
Antimicrobial Agent
12%